Literature DB >> 25033703

Rodent models of hepatic ischemia-reperfusion injury: time and percentage-related pathophysiological mechanisms.

Theodore Karatzas1, Anna-Aikaterini Neri2, Maria-Eleni Baibaki3, Ismene A Dontas4.   

Abstract

Ischemia and reperfusion (IR) injury remains one of the major problems in liver surgery and transplantation, which determines the viability of the hepatic tissue after resection and of the grafted organ. This review aims to elucidate the mechanisms involved in IR injury of the liver in rodent experimental studies and the preventative methods and pharmacologic agents that have been applied. Many time- and percentage-related liver IR injury rodent models have been used to examine the pathophysiological mechanisms and the parameters implicated with different morbidity, mortality, and pathology findings. The most preferred experimental rodent model of liver IR is the induction of 70% IR for 45 min, which is associated with almost 100% survival. In this model, plasma levels of several parameters such as alanine transaminase, aspartate aminotransferase, gamma-glutamyltransferase, endothelin-1, malonodialdehyde, tumor necrosis factor α, interleukin 1b, inducible nitric oxide synthase, and caspases are increased. The increase of caspases is associated with the initiation of hepatic cellular apoptosis. The main injuries observed 24 h after reperfusion are nuclear pyknosis, cytoplasmic hypereosinophilia, severe necrosis, and loss of intercellular borders. Both ischemic pre- and post-conditioning preventative methods and pharmacologic agents are successfully applied to alleviate the IR injuries. The selection of the time- and percentage-related liver IR injury rodent model and the potential preventative method should be related to the clinical question being answered.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Ischemia time; Ischemia–reperfusion injury; Liver injury; Liver percentage; Rodents

Mesh:

Year:  2014        PMID: 25033703     DOI: 10.1016/j.jss.2014.06.024

Source DB:  PubMed          Journal:  J Surg Res        ISSN: 0022-4804            Impact factor:   2.192


  19 in total

Review 1.  Pathophysiological Changes During Ischemia-reperfusion Injury in Rodent Hepatic Steatosis.

Authors:  Anna-Aikaterini Neri; Ismene A Dontas; Dimitrios C Iliopoulos; Theodore Karatzas
Journal:  In Vivo       Date:  2020 May-Jun       Impact factor: 2.155

2.  Direct orthotopic implantation of hepatic organoids.

Authors:  Vivian X Zhou; Macarena Lolas; Tammy T Chang
Journal:  J Surg Res       Date:  2016-12-29       Impact factor: 2.192

3.  Protein kinase C-β inhibitor treatment attenuates hepatic ischemia and reperfusion injury in diabetic rats.

Authors:  Guang-Xing Meng; Qiang Yuan; Li-Ping Wei; Hua Meng; Yi-Jun Wang
Journal:  Exp Ther Med       Date:  2015-12-09       Impact factor: 2.447

Review 4.  Melatonin role preventing steatohepatitis and improving liver transplantation results.

Authors:  Eduardo Esteban-Zubero; Francisco Agustín García-Gil; Laura López-Pingarrón; Moisés Alejandro Alatorre-Jiménez; José Manuel Ramírez; Dun-Xian Tan; José Joaquín García; Russel J Reiter
Journal:  Cell Mol Life Sci       Date:  2016-03-29       Impact factor: 9.261

Review 5.  Protective benefits of AMP-activated protein kinase in hepatic ischemia-reperfusion injury.

Authors:  Min Zhang; Dan Yang; Xianqiong Gong; Pu Ge; Jie Dai; Ling Lin; Li Zhang
Journal:  Am J Transl Res       Date:  2017-03-15       Impact factor: 4.060

6.  CCR2 dependent neutrophil activation and mobilization rely on TLR4-p38 axis during liver ischemia-reperfusion injury.

Authors:  Peng Xu; Junbin Zhang; Hui Wang; Guoliang Wang; Cong-Yi Wang; Jinxiang Zhang
Journal:  Am J Transl Res       Date:  2017-06-15       Impact factor: 4.060

7.  Intestinal translocation of clinical isolates of vancomycin-resistant Enterococcus faecalis and ESBL-producing Escherichia coli in a rat model of bacterial colonization and liver ischemia/reperfusion injury.

Authors:  Karin M van der Heijden; Inneke M van der Heijden; Flavio H Galvao; Camila G Lopes; Silvia F Costa; Edson Abdala; Luiz A D'Albuquerque; Anna S Levin
Journal:  PLoS One       Date:  2014-09-25       Impact factor: 3.240

Review 8.  Autophagy and liver ischemia-reperfusion injury.

Authors:  Raffaele Cursio; Pascal Colosetti; Jean Gugenheim
Journal:  Biomed Res Int       Date:  2015-03-15       Impact factor: 3.411

9.  Fate and Effect of Intravenously Infused Mesenchymal Stem Cells in a Mouse Model of Hepatic Ischemia Reperfusion Injury and Resection.

Authors:  T C Saat; S van den Engel; W Bijman-Lachger; S S Korevaar; M J Hoogduijn; J N M IJzermans; R W F de Bruin
Journal:  Stem Cells Int       Date:  2016-02-11       Impact factor: 5.443

Review 10.  Pharmacological Preconditioning by Adenosine A2a Receptor Stimulation: Features of the Protected Liver Cell Phenotype.

Authors:  Elisa Alchera; Chiara Imarisio; Giorgia Mandili; Simone Merlin; Bangalore R Chandrashekar; Francesco Novelli; Antonia Follenzi; Rita Carini
Journal:  Biomed Res Int       Date:  2015-10-11       Impact factor: 3.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.